Á¦21ȸ ¿µÈ£³² ³»ºÐºñ´ë»çÇÐȸ Çмú´ëȸ : 2019-02-17±³À°ÀÏÀÚ : 2019-02-17
±³À°Àå¼Ò : ¿ï»ê Çö´ëÁß°ø¾÷ ÀÎÀç°³¹ß¿ø ¼¼¹Ì³ª½Ç I
±³À°ÁÖÁ¦ :
Á¦21ȸ ¿µÈ£³² ³»ºÐºñ´ë»çÇÐȸ Çмú´ëȸÁÖÃÖ±â°ü : ´ëÇѳ»ºÐºñÇÐȸ
½ÃÇà±â°ü(ÁöºÎ/°ú) : ºÎ»ê¿ï»ê°æ³²Áöȸ
´ã´çÀÚ : Àü¾ðÁÖ
¿¬¶ôó : 053-650-4026
À̸ÞÀÏ :
0414mk@hanmail.net ±³À°Á¾·ù : ³»°ú
Âü¼®¿¹»óÀοø : 100¸í
Èñ¸ÁÆòÁ¡ : 2Á¡
Áö¿ª :
¿ï»ê±¤¿ª½Ã±³À°½Ã°£ : 2 ½Ã°£ 50ºÐ
¼¼ºÎ¼ö°·á : 30,000¿ø
ºñ°í °³¿øÀÇ, ºÀÁ÷ÀÇ »çÀüµî·Ï 3¸¸¿ø/ÇöÀåµî·Ï 4¸¸¿ø Àü°øÀÇ ¹«·á(»çÀüµî·ÏÇÊ)
±¸ºÐ ¿ùÀÏ °ÀÇ½Ç ½Ã°£ ±³À°Á¦¸ñ °»ç¸í(¼Ò¼Ó) Çʼö°ú¸ñ
±³À°½Ã°£ 02-17 ¼¼¹Ì³ª I 09:00~09:20 Hypoglycemia with insulin autoimmune syndrome induced by ¥á-lipoic acid À̼ÒÇö(°í½ÅÀÇ´ë)
Åä·Ð 02-17 ¼¼¹Ì³ª I 09:20~09:30 Åä·Ð ¹ÚÁ¤Çö(ÀÎÁ¦ÀÇ´ë)
±³À°½Ã°£ 02-17 ¼¼¹Ì³ª I 09:30~09:50 Checkpoint inhibitor »ç¿ë ÈÄ ¹ß»ýÇÑ diabetic ketoacidosis È«¾Æ¶÷(Àü³²ÀÇ´ë)
Åä·Ð 02-17 ¼¼¹Ì³ª I 09:50~10:00 Åä·Ð ¹ÚÁ¤Çö(ÀÎÁ¦ÀÇ´ë)
±³À°½Ã°£ 02-17 ¼¼¹Ì³ª I 10:00~10:20 Cases of acquired hypophosphatemic osteomalacia ÀÌ°æ¾Ö(ÀüºÏÀÇ´ë)
Åä·Ð 02-17 ¼¼¹Ì³ª I 10:20~10:30 Åä·Ð ÇÔÁ¾·Ä(°æ»óÀÇ´ë)
ÈÞ½Ä 02-17 10:30~10:50 ÈÞ½Ä ()
±³À°½Ã°£ 02-17 ¼¼¹Ì³ª I 10:50~11:10 2018 ACC/AHA Multisociety Guideline on the Management of Blood Cholesterol ¼¼ºÈ¯(µ¿¾ÆÀÇ´ë)
±³À°½Ã°£ 02-17 ¼¼¹Ì³ª I 11:10~11:30 Calcium metabolism and management ¼Çö¾Ö(´ë±¸ÆÄƼ¸¶º´¿ø)
±³À°½Ã°£ 02-17 ¼¼¹Ì³ª I 11:30~11:50 Treatment options in hyperthyroidism and how to monitor and evaluate the effect of treatment ¿Á¼Ò¿µ(°í½ÅÀÇ´ë)
Åä·Ð 02-17 ¼¼¹Ì³ª I 11:50~12:10 Åä·Ð Á¤µ¿Áø(Àü³²ÀÇ´ë)